PetIQ (PETQ) Days Payable : 54.06 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is PetIQ Days Payable?

PetIQ's average Accounts Payable for the three months ended in Mar. 2024 was $139 Mil. PetIQ's Cost of Goods Sold for the three months ended in Mar. 2024 was $234 Mil. Hence, PetIQ's Days Payable for the three months ended in Mar. 2024 was 54.06.

The historical rank and industry rank for PetIQ's Days Payable or its related term are showing as below:

PETQ' s Days Payable Range Over the Past 10 Years
Min: 19.96 Med: 30.13 Max: 59.32
Current: 59.32

During the past 9 years, PetIQ's highest Days Payable was 59.32. The lowest was 19.96. And the median was 30.13.

PETQ's Days Payable is ranked worse than
67.08% of 975 companies
in the Drug Manufacturers industry
Industry Median: 88.64 vs PETQ: 59.32

PetIQ's Days Payable increased from Mar. 2023 (52.58) to Mar. 2024 (54.06). It may suggest that PetIQ delayed paying its suppliers.

PetIQ Days Payable Historical Data

The historical data trend for PetIQ's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetIQ Days Payable Chart

PetIQ Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

32.22

33.87

30.13

43.08

54.21

PetIQ Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															52.58	57.66	59.73	65.54	54.06

Competitive Comparison of PetIQ's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, PetIQ's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PetIQ's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PetIQ's Days Payable distribution charts can be found below:

* The bar in red indicates where PetIQ's Days Payable falls into.

PetIQ Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

PetIQ's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (112.995	+	139.264)	/	2 )	/	849.223	*	365
=	126.1295					/	849.223	*	365
=	54.21

PetIQ's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (139.264	+	137.862)	/	2 )	/	233.9	*	365 / 4
=	138.563					/	233.9	*	365 / 4
=	54.06

PetIQ Days Payable Related Terms

Thank you for viewing the detailed overview of PetIQ's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

PetIQ (PETQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PetIQ Inc (NAS:PETQ) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

39L:Germany

Address

230 East Riverside Drive, Eagle, ID, USA, 83616

Website

https://www.petiq.com

PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time were primarily available from veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment.

Executives

William J. Carter	officer: EVP, GENERAL COUNSEL	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
John Paul Pearson	officer: EVP, Services & Manufactured	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Robert Michael Herrman	officer: General Counsel and Secretary	923 SOUTH BRIDGEWAY PLACE, EAGLE ID 83616
Michael A Smith	officer: EVP - Products	923 S. BRIDGEWAY PLACE, C/O PETIQ, INC., EAGLE ID 83616
Kimberly Lefko	director	923 S. BRIDGEWAY PLACE, EAGLE ID 83616
Sheryl Oloughlin	director	923 S. BRIDGEWAY PLACE, EAGLE ID 83616
Scott Huff	director	923. S. BRIDGEWAY PLACE, EAGLE ID 83616
Allan Hall	director	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Zvi Glasman	officer: Chief Financial Officer	C/O FOX FACTORY HOLDING CORP., 915 DISC DRIVE, SCOTTS VALLEY CA 95066
Kenneth C. Walker	director	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Susan Sholtis	director	C/O PETIQ, INC., 500 E. SHORE DRIVE, SUITE 120, EAGLE ID 83616
Mccord Christensen	director, officer: Chief Executive Officer	500 EAST SHORE DRIVE, SUITE 120, EAGLE ID 83616
John Newland	officer: Chief Financial Officer	C/O TRUE SCIENCE LLC, 500 E. SHORE DRIVE SUITE 120, EAGLE ID 83616
Ronald Kennedy	director, 10 percent owner	500 EAST SHORE DR, SUITE 120, EAGLE ID 83616
Ecp Helios Partners Iv, L.p.	10 percent owner	437 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10022